Skip to the content
VACCINES PRODUCTION
Production of specific veterinary vaccines adapted to the various epidemiological contexts in Morocco and abroad.
BIOPHARMA
BIOPHARMA's expertise in vaccine production has facilitated the establishment of a robust research platform for the development of specific veterinary vaccines, utilizing field isolated strains.
BIOPHARMA's expertise in vaccine production has facilitated the establishment of a robust research platform for the development of specific veterinary vaccines, utilizing field isolated strains.
These highly effective vaccines have played a pivotal role in combating contagious animal diseases through comprehensive control plans and nationwide or regional vaccination programs.
The success of Morocco’s efforts to combat severe epizootics such as African Horse Sickness, Foot and Mouth Disease, Bluetongue, Peste des Petits Ruminants, among others, can be attributed to BIOPHARMA’s agility in manufacturing vaccines of indisputable effectiveness at competitive costs, tailored to the national epidemiological landscape.
BIOPHARMA’s unwavering commitment to fulfilling its mission has been evident through its prompt response to emerging challenges. In 2019, following the resurgence of Foot-and-Mouth Disease in Morocco, BIOPHARMA swiftly mobilized its resources. In record time, the company developed and provided veterinary health authorities with the necessary vaccine, comprising scientifically recommended strains, and at a reduced cost.
This rapid response, coupled with the expeditious vaccination of the national livestock population, including cattle and small ruminants, facilitated disease containment. Consequently, it mitigated the spread of the disease across various regions of Morocco, safeguarding animal welfare and preserving the integrity of the livestock sector.
BIOPHARMA’s demonstrated ability to anticipate and address evolving animal health threats underscores the critical role of such infrastructure in supporting decision-makers in the execution and implementation of animal health policies. As the landscape of animal health continues to evolve, BIOPHARMA remains poised to contribute significantly to disease control and prevention efforts, providing essential support to veterinary health authorities and ensuring the resilience of Morocco’s livestock industry.
